Skip to main content
. 2017 Aug 23;8:1591. doi: 10.3389/fmicb.2017.01591

Figure 2.

Figure 2

Mutations N107A, G109A, and E148A in TaP decreases the inhibitory effect of tolfenamic acid on PrbP/DNA interactions. The PrplK probe and 3.5 μM of each of the PrbP mutants (N107A, G109A, and E148A, as indicated in the top of each panel) were incubated with increasing concentrations (0–500 μM) of tolfenamic acid as indicated. TA, tolfenamic acid; First lane of each panel has no protein added. Ratio was calculated by the band intensity of protein: DNA complex and total DNA. Quantification was based on observations from at least 2 replicates.